Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This lancet study was just released today and has the largest N of any observational study to date. Those institutions are guided by poor science and even poorer decision makers.
Not that it’s any of your business, but I’m demanding an eIND from my doctor for leronlimab. Provide me with a link for a study (NOT A SURVEY) supporting HCQs efficacy. Thanks!
You took my words out of context. It has saved millions from dying from malaria. As it relates to covid-19 - it will kill more than it saves.
*for covid19. It has saved many from malaria!
You should ask all the families of the veterans that died because they were prescribed it for covid19.
One more time for the people in the back!
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext
Hi, that was the HCQ + AZT group that did EVEN WORSE than the HCQ only group. It’s a drug that will pan out to have caused more harm/mortality than lives it saved.
I invested because of HIV. Still waiting for someone to post a double-blind, placebo controlled study supporting HCQs efficacy. Do you know why it hasn’t been done? Meanwhile, HCQ failed efficacy in the spectrum of mild to severe covid19, but now ask has a higher mortality & VT in hospitalized patients:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext
Furthermore, the addition of a macrolide antibiotic (1 of which was azithromycin) added substantially to risk of ventricular tachycardia: HCQ 2.3X-> H+M 5.1X risk.
So you can’t provide me one study supporting HCQ’s efficacy? Understood.
And I still welcome you to publish a study justifying its efficacy and I will re-evaluate. I don’t want an article about some doctor said something would work.
Sadly, people continue promote HCQ without a single well-controlled clinical trial.
Good thing they are “experimenting” with a drug to “confirm anecdotal evidence”.
The more people continue to prop up failed drugs like HCQ and remdesivir, the less exposure and more difficult it will be to expedite leronlimab. But, but, but, but, zinc!
The largest study of hydroxychloroquine shows a significant increase in death (~35%) and >2-fold increase of serious heart arrhythmias. ~96,000 patients, ~15,000 on HCQ or CQ from 671 hospitals, 6 continents.[/
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31180-6/fulltext
Zinc actually has antiviral properties and your body chews through vitamin C in high inflammatory states. HCQ is immunosuppressive in covid patients which explains the higher mortality rate when given to sicker patients (VA study). So you’re probably not wrong..
I’ve already nominated him.....
Dr. Bruce is in a league of his own. He is leaps and bounds above his colleagues in identifying the pathogenesis of this virus and articulating how it morphs in to the immunologic response that causes mortality. He truly deserves the most credit when leronlimab is allowed to eventually bring this pandemic to a manageable state.
Yes. Found it interesting that the presenter before Dr. Bruce Patterson said that hydroxychloroquine doesn’t work and couldn’t figure out the states obsession with it. We are going no where with the inept coronavirus task force.
The revolving door of former big pharmaceutical executives in FDA leadership laughs richly at your inquisition.
I would expect nothing less ONCE we have interim data for the covid trial.
I have hydrogen peroxide
I agree. We do not want leronlimab being associated with bleach or other unproven adjuncts. Let the science speak for itself!
Amen
Smart money getting out of Gilead!
A Smart Pension Manager Sold Apple, GE, and Gilead Stock. Here’s What It Bought.
www.barrons.com/amp/articles/a-smart-pension-manager-sold-apple-ge-and-gilead-stock-spy-etf-51589408831
It will be undeniable at that point....unless the FDA requests more data
What’s remdesivir’s excuse?
I posted my “crazy” theory on here before that the FDA is sandbagging leronlimab. I’m convinced of it more now than ever. I can distinctly picture Dr. Patterson’s face on a recent call when asked why it wasn’t approved yet. He looked completely perplexed.
Exactly. Both drugs are worthless against covid (and likely more harmful) and continue to be touted. I sense class actions coming for both drugs in the future.
COVID patients given malaria drug didn't see significant improvements: studies
https://www.reuters.com/article/us-health-coronavirus-usa-hydroxychloroq/covid-patients-given-malaria-drug-didnt-see-significant-improvements-studies-idUSKBN22Q37C
In a randomized, controlled trial of 150 patients with mild to moderate COVID-19 in China, researchers found that patients on hydroxychloroquine did not get better significantly faster than those not treated with the drug. Adverse events were also higher in patients receiving the malaria drug.
Dr. Gupta actually briefly touched on this topic yesterday when discussing the pathophysiology of covid19.
Unfortunately this isn’t completely irrational - Gilead did something not so dissimilar with remdesivir....
More evidence that hydroxychloroquine doesn’t work:
https://www.nejm.org/doi/full/10.1056/NEJMoa2012410
Hydroxychloroquine doesn’t work, remdesivir doesn’t work, and bleach doesn’t work (need more anecdotal evidence).
When will the inept coronavirus task force talk about leronlimab?
I’d be pretty skeptical of AYTU. The only time I sold CYDY shares was to buy in a company called Innovus Pharmaceuticals. They had OTC rights to Fluticare and other products, but the company was completely mismanaged by the CEO, went through a heavy reverse split, changed the name of the company to AYTU, and now they’re marketing this covid19 light. Not saying it’s not a legit product, but I would just be very skeptical. I’m waiting to dump my AYTU bag so I can write off against CYDY.
I like how dr. Bruce Patterson keeps reiterating “statistical significance”. The one thing Remdesivir does not have with regard to their “decreased mortality” study results.
Weird feeling that the FDA will come back and ask for another study, larger patient population, or additional safety data.
And the swamp grows bigger
I was pretty upset with the “developments” regarding remdesivir today, but you might be right. Remdesivir has just set the standard of care for treatment of covid-19. Leronlimab’s data will be FAR SUPERIOR to remdesivir when we are able to release our results. The one thing that worries me is that since they will be first to approval, there’s a chance that subsequent therapeutics will be overlooked. Especially considering Gileads deep pockets, congressional power, and ability to market.
And I think that’s exactly the question that needs to be asked:
If a big pharmaceutical owned this IP - would the drug have been approved for use already?
Agreed! If he truly had the smartest people on his task force, they would have easily been able to recognize that leronlimab has the most promise of any drug.
What’s the path/timeline for uplisting to a major exchange?